Twist Bioscience TWST Income Statement (2017-2026)

NASDAQ TWST
$111.62 -4.73 (-4.07%)
At close: Nov 19, 2026 · 4:00 PM EST
Reported Financials

Twist Bioscience Quarterly Income Statement

Periods 37 quarters
Latest Sep 2026
Industry Template General

Twist Bioscience reported revenue of $126.64M and net income of -$20.65M for the quarter ended Sep 2026, up 27.9% year over year. This income statement covers 37 quarters of results from Sep 2017 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Revenue & cost
Revenue
42.02M48.13M56.11M57.31M54.24M60.18M63.74M66.95M71.50M75.30M81.46M84.71M88.71M92.79M96.06M99.01M103.70M110.72M118.38M126.64M
Cost of RevenueCost of Rev
27.06M29.71M30.97M31.59M29.44M41.67M41.85M42.42M42.54M44.42M46.19M46.48M45.87M46.77M44.76M48.17M49.73M53.59M55.92M59.39M
Gross Profit
14.96M18.41M25.14M25.72M24.80M18.51M21.90M24.52M28.96M30.88M35.27M38.23M42.84M46.03M51.30M50.84M53.97M57.12M62.45M67.25M
Operating items
Research & DevelopmentR&D
22.63M31.23M36.84M29.61M31.24M27.38M24.53M23.75M23.10M24.15M22.47M21.13M21.31M23.92M18.05M17.01M17.13M19.70M18.03M16.99M
Share-based Compensation (IS)Stock Comp.
Selling, General & AdministrativeSG&A
51.10M54.00M53.69M54.16M42.32M53.97M46.06M47.39M52.84M55.62M56.79M53.14M56.18M63.67M63.37M63.76M69.74M76.09M80.71M74.68M
Restructuring CostsRestructuring
9.05M0.33M
Other Operating ExpensesOther Opex
2.83M6.01M4.23M1.17M4.14M1.20M0.58M45.87M49.73M7.21M
Operating ExpensesOpex
97.96M108.93M117.28M114.18M98.87M121.82M124.52M117.06M118.48M124.19M170.39M120.75M123.36M134.35M126.18M128.94M136.60M156.58M154.66M151.06M
Operating IncomeOp. Inc
-55.94M-60.80M-61.16M-56.87M-44.63M-61.64M-60.78M-50.11M-46.98M-48.89M-88.92M-36.04M-34.64M-41.56M-30.12M-29.93M-32.90M-45.86M-36.28M-24.41M
Non-operating items
Non Operating Interest Expenses
0.03M0.03M0.03M0.00M0.00M0.00M0.00M0.03M0.02M0.14M
Goodwill impairment chargesGoodwill Impair.
3.62M3.17M44.93M
Gains (Losses) on Sale of Assets & InvestmentsGains on Sales
0.28M-1.11M-0.40M6.40M-0.87M0.65M-0.21M-1.31M0.13M-0.06M-0.07M0.03M48.85M0.02M-0.09M
Interest & Investment IncomeInt & Inv Inc
0.15M0.26M0.72M1.93M3.04M3.46M3.97M3.89M4.12M3.94M3.66M3.62M3.24M2.80M2.69M2.63M2.18M1.71M1.50M3.42M
Other Non Operating IncomeOther Non Op Inc.
-0.16M-0.25M-0.23M-0.46M-0.16M-0.31M0.04M-0.25M-0.03M-0.20M-0.12M-2.33M-0.09M-0.39M-0.84M0.42M0.47M0.18M0.04M0.17M
Non Operating IncomeNon Op. Inc.
-0.12M-2.33M-0.39M-0.84M0.42M0.18M0.04M0.17M
Net income details
EBIT
-55.94M-60.80M-61.16M-56.87M-44.63M-61.64M-60.78M-50.11M-46.98M-48.89M-88.92M-36.04M-34.64M-41.56M-30.12M-29.93M-32.90M-45.86M-36.28M-24.41M
EBT
-55.97M-60.82M-60.67M-50.82M-41.75M-58.48M-56.77M-46.47M-42.89M-45.15M-85.38M-34.75M-31.50M-39.15M20.58M-26.88M-30.25M-43.98M-34.74M-20.82M
Tax ProvisionsTaxes
-10.41M-0.15M-0.15M0.29M0.08M0.70M0.62M-0.20M0.12M0.35M0.20M-0.10M0.10M0.20M0.20M0.22M0.30M0.04M0.31M-1.01M
Income After Tax
-45.56M-60.67M-60.52M-51.12M-41.82M-59.18M-57.40M-46.27M-43.01M-45.49M-85.58M-34.65M-31.60M-39.35M20.38M-27.10M-30.55M-44.02M-35.05M-19.81M
Income from Continuing OperationsIncome (Continuing)
-45.56M-60.67M-60.52M-51.12M-41.82M-59.18M-57.40M-46.27M-43.01M-45.49M-85.58M-34.65M-31.60M-39.35M20.38M-27.10M-30.55M-44.02M-35.05M-19.81M
Consolidated Net IncomeConsol Net Inc.
-45.38M-61.51M-61.42M-51.58M-43.06M-58.44M-58.14M-46.36M-42.82M-45.59M-85.65M-34.44M-31.72M-39.32M20.19M-26.90M-30.45M-44.09M-35.07M-20.65M
Net Income Attributable to Noncontrolling InterestsNCI Net Income
-85.65M20.19M
Income towards Parent CompanyParent Net Inc
-45.56M-60.67M-60.52M-51.15M-41.82M-59.16M-57.40M-46.24M-43.01M-45.50M-85.60M-34.63M-31.60M-39.33M20.40M-27.17M-30.51M-44.02M-35.10M-20.62M
Net Income towards Common StockholdersNet Income
-45.56M-60.67M-60.52M-51.15M-41.82M-59.16M-57.40M-46.24M-43.01M-45.50M-85.60M-34.63M-31.60M-39.33M20.40M-27.17M-30.51M-44.02M-35.10M-20.62M
Additional items
EPS (Basic)
-0.91-1.13-1.08-0.95-0.74-1.04-1.01-0.81-0.75-0.79-1.47-0.60-0.53-0.660.34-0.45-0.50-0.71-0.56-0.33
EPS (Diluted)
-0.91-1.13-1.08-0.95-0.74-1.04-1.01-0.81-0.75-0.79-1.47-0.60-0.53-0.660.33-0.45-0.50-0.71-0.56-0.33
Shares Outstanding
49.91M53.47M56.29M53.89M56.44M56.78M57.04M56.89M57.50M57.78M58.15M58.02M59.16M59.65M60.00M59.81M61.08M61.70M62.40M62.40M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
49.91M53.47M56.29M53.89M56.44M56.78M57.04M56.89M57.50M57.78M58.15M58.02M59.16M59.65M61.16M59.81M61.08M61.70M62.40M62.40M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
50.74M56.23M56.34M56.52M56.65M57.11M57.37M57.56M57.78M58.16M58.52M58.88M59.58M59.86M60.17M60.63M61.27M62.15M62.67M62.62M
EBITDA
-52.79M-56.83M-56.72M-51.92M-39.34M-54.61M-52.29M-41.61M-38.81M-40.59M-80.62M-29.39M-28.26M-35.16M-24.06M-23.93M-26.71M-39.45M-29.50M-17.32M
Interest ExpensesInt Expense
0.03M0.03M0.03M0.00M0.00M0.00M0.00M0.03M0.02M0.14M
Tax Rate
0.97%

Twist Bioscience Income Statement API

Pull Twist Bioscience's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=TWST&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY